NOS3 and diabetes mellitus: It is generally accepted that DM impairs endothelial nitric oxide synthase (eNOS) activity and increases the production of reactive oxygen species (ROS), thus resulting in reduced NO bioavailability and the consequent pro-atherogenetic alterations (3).